drugset / Trial / NCT06784843
Dexmedetomidine Versus Midazolam for Peribulbar Block
RandomizedParallel-groupDouble-blindTreatment
Summary
50 patients of both sexes, ages 18 to 75, who were scheduled for cataract surgery and had physical status I or II according to the American Society of Anesthesiologists were included in this study. After induction of general anesthesia, all patients received peribulbar block. In group A (midazolam group), 25 patients received midazolam. In group B (dexmedetomidine group), 25 patients received dexmedetomidine.
Timeline
- Start
- 2023-12-01
- Primary completion
- 2024-08-30
- Completion
- 2024-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 50 ug | — |
| Comparator | Midazolam | Small molecule | 1 mg | — |